A destabilizing Y891D mutation in activated EGFR impairs sensitivity to kinase inhibition
Daniel S. Lenchner(Yale Cancer Center), Frederick H. Wilson(Yale Cancer Center)
Cited by 4
Related Papers
Genetic and oncogenic features of RASGRF fusions
|npj Precision Oncology|2025|2